GLP-1 meaning: the hormone, the medications and the words that come with them

Here is the GLP-1 meaning in one line: the letters are short for glucagon-like peptide-1, a hormone made in your gut that goes to work after a meal.1 It helps steady blood sugar, slows the stomach and acts on the brain’s appetite centers.

Most people who use the term today are not talking about the hormone, though. They mean prescription medications built to act like it, such as Wegovy, Zepbound, Ozempic and Mounjaro.

Written by the FitRx care team. Last updated November 18, 2026. Sources are listed in the references.

Key takeaways

  • The letters GLP-1 abbreviate glucagon-like peptide-1, a gut hormone released when you eat.1
  • The hormone signals for insulin when blood sugar is high, turns glucagon down, slows stomach emptying and acts on appetite centers in the brain.1,2
  • “A GLP-1” in conversation is nearly always a prescription GLP-1 receptor agonist, a medicine that works on the same receptor and outlasts the natural hormone by a wide margin.
  • Wegovy and Zepbound are FDA-approved for weight management, while Ozempic and Mounjaro are approved for type 2 diabetes and are not approved for weight loss.3,4,5,6
  • Trial results are averages, and a licensed provider decides whether any of these medications is appropriate for you.

See if you qualify

What do the letters in GLP-1 stand for?

The full name is glucagon-like peptide-1. GLP-1 is a hormone, which is to say a chemical messenger. Cells lining your intestine make it and send it into the bloodstream once food shows up.1

Piece by piece:

  • Glucagon-like. Glucagon is a different hormone, one that pushes blood sugar up. GLP-1 resembles it chemically, which is where the name comes from, but it does not share the job. GLP-1 lowers glucagon.1
  • Peptide. A string of amino acids, far shorter than a full protein.
  • 1. The number sets it apart from a sister hormone, GLP-2, which is not what these medications copy.1

One term, two uses

In a science article, GLP-1 is the hormone. Nearly everywhere else, it is a medication. “I started a GLP-1” means a prescription such as Wegovy or Zepbound.

Those drugs have a formal name: GLP-1 receptor agonists. Cells carry receptors, which work like docking sites for hormones. An agonist is anything that attaches to a receptor and turns it on. Put together, the phrase describes a medicine that turns on the receptor your own GLP-1 uses.2 You will also see it written “GLP-1 RA” or “GLP-1 agonist.”

How does GLP-1 work in your body?

Think of GLP-1 as a mealtime signal. Your gut sends it out after you eat, and several organs respond at once.1

OrganWhat natural GLP-1 does thereWhat that looks like with the medications
PancreasSignals for more insulin when blood sugar is high, and turns glucagon downBlood sugar control in type 2 diabetes is an approved use of Ozempic and Mounjaro
StomachMakes the stomach empty more slowlyThe labels note delayed stomach emptying, which can change how other medicines taken by mouth are absorbed
BrainWorks on the centers that regulate appetiteLess appetite. The Mounjaro label lists decreased appetite among its common side effects

Physiology from published reviews.1,2 Medication details from the prescribing information.5,6

Why your own GLP-1 does not last

Natural GLP-1 is a short message. Your body breaks it down within minutes of releasing it.1

The medications are built to last much longer.2 The semaglutide and tirzepatide injections are taken once a week, and the tablets once a day. The Ozempic label notes that semaglutide stays in the body a long time and says to stop it at least 2 months before a planned pregnancy.5

Which medications are GLP-1s?

A GLP-1 medication is a prescription drug that turns on the GLP-1 receptor. Some are approved for type 2 diabetes and some for long-term weight management. The brand name decides which, even when the ingredient inside is the same.

BrandActive ingredientWhat the FDA approved it forHow it is taken
OzempicSemaglutideAdults with type 2 diabetes: blood sugar control; lower risk of major cardiovascular events in those with established cardiovascular disease; lower risk of kidney function decline, kidney failure and cardiovascular death in those with chronic kidney disease. Not approved for weight loss.5Weekly injection
Ozempic tablets and RybelsusSemaglutideType 2 diabetes only: blood sugar control, and lower cardiovascular risk in adults with type 2 diabetes at high risk.7Daily tablet, on an empty stomach
Wegovy injectionSemaglutideWeight reduction and long-term maintenance in adults and children 12 and older with obesity, and adults with overweight plus a weight-related condition. Also cardiovascular risk reduction and a liver condition called MASH in certain adults.3Weekly injection
Wegovy tabletsSemaglutideWeight reduction and maintenance in adults with obesity, or with overweight plus a weight-related condition, and cardiovascular risk reduction in certain adults.3Daily tablet, on an empty stomach
MounjaroTirzepatide (GIP and GLP-1)Type 2 diabetes: blood sugar control in adults and children 10 and older, and lower risk of major cardiovascular events in adults at high risk. Not approved for weight loss.6Weekly injection
ZepboundTirzepatide (GIP and GLP-1)Weight reduction and long-term maintenance in adults with obesity, or with overweight plus a weight-related condition, and moderate to severe obstructive sleep apnea in adults with obesity.4Weekly injection
FoundayoOrforglipronWeight reduction and maintenance in adults with obesity, or with overweight plus a weight-related condition.8Daily tablet, with or without food

Summarized from each product’s prescribing information. The Wegovy and Zepbound weight approvals are for use with a reduced-calorie diet and more physical activity. FitRx does not offer Foundayo; it is listed for context.

Same ingredient, different brand

Semaglutide is sold as Ozempic and Wegovy. Tirzepatide is sold as Mounjaro and Zepbound. Within each pair the ingredient is the same and the approved use is not. Ozempic and Mounjaro are diabetes medications. Wegovy and Zepbound are the brands approved for weight management.

Is tirzepatide really a GLP-1?

Strictly, it is more than one. Tirzepatide works on two receptors, the GLP-1 receptor and the receptor for another gut hormone called GIP, and its label names both: a GIP and GLP-1 receptor agonist.4 Semaglutide is labeled simply as a GLP-1 receptor agonist.5

Other names in the family

Foundayo, first approved in 2026, is a small-molecule GLP-1 receptor agonist taken as a daily tablet.8 You may also hear about liraglutide (Saxenda, Victoza) and dulaglutide (Trulicity). As of November 18, 2026, the FDA’s shortage database listed Saxenda and Rybelsus tablets as to be discontinued and Victoza as having limited availability, with no shortage record for Trulicity or for any semaglutide or tirzepatide injection.9

What do GLP-1 medications do for weight loss?

When the subject is weight, “GLP-1” refers to a prescription medication whose main effect is on appetite. It slows the stomach and acts on the brain’s appetite centers, which makes eating less easier to keep up.2

The Wegovy and Zepbound labels cover adults with obesity (a BMI of 30 or higher) and adults with overweight (a BMI of 27 or higher) who have at least one weight-related condition.3,4 The BMI calculator shows where you fall. A provider makes the final call.

What the trials found, on average

MedicationTrialLengthAverage weight lostPlacebo group
Wegovy injection (semaglutide)STEP 11068 weeks14.9%2.4%
Wegovy tablets, 25 mgOASIS 4364 weeks13.6%2.4%
Zepbound (tirzepatide) 5, 10 and 15 mgSURMOUNT-11172 weeks15.0%, 19.5% and 20.9%3.1%
Foundayo (orforglipron) 5.5, 9 and 17.2 mgLabel data872 weeks7.4%, 8.3% and 11.1%2.1%

Average change in body weight. The STEP 1, SURMOUNT-1 and Foundayo figures are for adults without diabetes. The trials enrolled different people, so the rows are not a like-for-like comparison. Individual results vary.

One trial did compare two of them directly. SURMOUNT-5 assigned 751 adults with obesity and without diabetes to tirzepatide or semaglutide, each at the highest dose the person could tolerate. After 72 weeks the average loss was 20.2% with tirzepatide and 13.7% with semaglutide.12

Two cautions. These are averages: some people lost more, some less. And Ozempic and Mounjaro, although weight fell in their diabetes trials, are approved for type 2 diabetes and are not FDA-approved for weight loss.5,6

What happens when the medication stops?

Weight tends to return. In the STEP 1 extension, a year after stopping semaglutide, participants had regained 11.6 percentage points of the 17.3% they had lost.13 In SURMOUNT-4, adults who had lost an average of 20.9% over 36 weeks on tirzepatide either continued or switched to placebo. By week 88 those who continued had lost a further 5.5%, and those who stopped had regained 14.0%.14

What about muscle?

Weight lost on any plan, medication included, is not all fat. Some of it is lean mass.15 Eating enough protein and keeping up strength training are the usual ways to protect it, and the protein calculator gives you a daily target.

What do the common GLP-1 words mean?

TermPlain meaning
Receptor agonistSomething that attaches to a receptor and turns it on.
GIPShort for glucose-dependent insulinotropic polypeptide, another gut hormone. Tirzepatide switches on its receptor along with the GLP-1 receptor.4
SemaglutideThe drug inside Ozempic, Wegovy and Rybelsus. A GLP-1 receptor agonist.
TirzepatideThe drug inside Mounjaro and Zepbound. A GIP and GLP-1 receptor agonist.
TitrationRaising the dose in stages. Zepbound, for example, starts at 2.5 mg a week for 4 weeks, and each later increase comes after at least 4 weeks on the current dose.4
Maintenance doseThe steady dose that follows the step-up period. For weight management the Zepbound label lists 5, 10 or 15 mg a week.4
BMIBody mass index: your weight relative to your height, used for screening. The CDC defines overweight as 25 to less than 30 and obesity as 30 or greater.16
A1cA lab value that tracks blood sugar averaged over recent months. Trials of Ozempic and Mounjaro report changes in it.
Food noiseA popular name for persistent thoughts about food that are hard to switch off.17 The food noise score calculator puts a number on it.
Prior authorizationA health plan’s sign-off, requested by your prescriber, before the plan pays for a medication. The GLP-1 insurance checker explains the process.
CompoundedMade to order by a compounding pharmacy for one patient’s prescription. Compounded semaglutide and compounded tirzepatide are not FDA-approved, are not reviewed by the FDA for safety, effectiveness or quality, and are not generics.18
Boxed warningThe most prominent warning on a prescription label, printed inside a box. The Ozempic, Wegovy, Mounjaro and Zepbound labels carry one about thyroid C-cell tumors.
PipelineMedications still in trials or under FDA review. The GLP-1 pipeline tracker lists them by class and phase.

What do people mistake GLP-1 for?

Five mix-ups come up again and again. GLP-1 is none of these.

A stimulant

A stimulant speeds up the nervous system. A GLP-1 medication does something different: it copies a gut hormone and acts where that hormone acts, in the pancreas, stomach and brain.2 That does not mean the heart is untouched. The Wegovy label lists an increase in heart rate as something to monitor.3

Insulin

Insulin is a separate hormone. What GLP-1 does is signal your pancreas to release its own when blood sugar is high.1 A GLP-1 medication is not a substitute for insulin, and the labels warn about low blood sugar in people who take both, or who take a sulfonylurea.3,4

A supplement

Every GLP-1 medication on this page requires a prescription. So a product sold over the counter under a GLP-1 name, in a store or online, is not one of these medicines. Separately, the FDA says counterfeit Ozempic and products labeled “for research purposes” are illegal, and that people should buy only from state-licensed pharmacies.18

A short course

For most people it is not. The weight management labels describe reducing weight and keeping it off long term.3,4 In SURMOUNT-4, 89.5% of people who stayed on tirzepatide kept at least 80% of their earlier loss, compared with 16.6% of those switched to placebo.14 Stopping is a decision to plan with a provider.

A generic, when it is compounded

A generic is a copy that the FDA has reviewed and approved. Compounded semaglutide and compounded tirzepatide are something else: medication made to order by a compounding pharmacy. They are not FDA-approved. The FDA does not check them for safety, effectiveness or quality before they reach patients, and they were not tested in the brand-name trials. They are not generics of Ozempic, Wegovy, Mounjaro or Zepbound.18

The FDA says compounded drugs should be used only when a patient’s medical needs cannot be met by an FDA-approved drug, and it treats a seller’s claim that a compounded drug is the same as an approved one as a red flag.18 Whether a compounded medication is appropriate is a licensed provider’s decision.

What should you know about GLP-1 side effects and safety?

Stomach and gut complaints lead the list. All four semaglutide and tirzepatide injection labels name nausea, diarrhea, vomiting, constipation and stomach pain among their most common side effects.3,4,5,6 In trials these clustered in the weeks when doses were stepping up.5,12

Medication and doses studiedNausea on the medicationNausea on placebo
Wegovy injection, 2.4 mg44%16%
Zepbound 5, 10 and 15 mg25%, 29% and 28%8%
Ozempic 0.5 and 1 mg15.8% and 20.3%6.1%
Mounjaro 5, 10 and 15 mg12%, 15% and 18%4%

From the placebo-controlled trials in each label.3,4,5,6 The trials differ in who took part and at what dose, so compare with care.

The boxed warning, in plain words. Semaglutide and tirzepatide caused thyroid C-cell tumors in rodent studies. Whether they do so in people is not known. Anyone who has had medullary thyroid carcinoma (MTC), has a family member who has, or has a condition called MEN 2 should not take them. Tell your provider about a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath.

The labels also warn about pancreatitis, gallbladder problems, kidney injury from dehydration, severe stomach problems, serious allergic reactions, low blood sugar when combined with insulin or a sulfonylurea, eye complications in people with type 2 diabetes, food or liquid entering the lungs during anesthesia, and possible harm to an unborn baby.3,4 Severe stomach pain that will not go away is a reason to get medical help.

For the fuller picture, including what is common, what is serious and how long it tends to last, read the GLP-1 side effects guide.

Who decides whether a GLP-1 fits you?

A licensed provider who has seen your health history, not a quiz or an ad. At FitRx you fill out an online intake and a U.S.-licensed provider reviews it, typically within 1 to 2 business days. If medication is appropriate, the prescription goes to a partner pharmacy, and for brand-name GLP-1s an insurance coordination team submits the prior authorization. Not everyone qualifies, and FitRx does not work with government insurance such as Medicare, Medicaid or TRICARE.

See if you qualify

GLP-1 meaning: quick answers to common questions

What do the letters GLP-1 stand for?

Glucagon-like peptide-1. That is the name of a hormone your gut makes and releases when you eat. It plays a part in blood sugar control, in how fast the stomach empties and in appetite.

What does GLP-1 mean when people talk about weight loss?

They mean a prescription medication that acts on the GLP-1 receptor and reduces appetite. Wegovy and Zepbound are FDA-approved for long-term weight management in adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition. Ozempic and Mounjaro are approved for type 2 diabetes and are not approved for weight loss.

Are GLP-1 and Ozempic the same thing?

No. Ozempic is a brand name for semaglutide, one medication among several that people call GLP-1s. The FDA approved Ozempic for adults with type 2 diabetes, not for weight loss. Wegovy contains semaglutide too and is the brand approved for weight management.

What is a GLP-1 receptor agonist?

It is the technical term for the medications people call GLP-1s. Cells carry receptors, which work like docking sites for hormones, and an agonist is anything that attaches to a receptor and turns it on. These medicines turn on the receptor your own GLP-1 uses and keep working far longer than the hormone.

Is GLP-1 a hormone or a medication?

The word covers both. Strictly, GLP-1 is a hormone your gut produces. In clinics, pharmacies and everyday talk it has also become the name for prescription medicines built to act on the same receptor, such as Wegovy, Zepbound, Ozempic and Mounjaro.

Does your body make its own GLP-1?

Yes. Everyone's gut makes it, and a meal is the trigger. The natural hormone is gone within minutes, so each burst is brief. The medications last much longer, which is why a dose is taken once a week or once a day.

Does tirzepatide count as a GLP-1?

Yes, and a bit more. Tirzepatide, sold as Mounjaro and Zepbound, works on two receptors: the one for GLP-1 and the one for another gut hormone, GIP. Its label calls it a GIP and GLP-1 receptor agonist. In everyday use it still gets filed under GLP-1s.

Is GLP-1 a kind of insulin?

No. Insulin and GLP-1 are different hormones. GLP-1 signals the pancreas to release insulin when blood sugar is high. The medications are not a substitute for insulin. Their labels warn that low blood sugar can happen when they are combined with insulin or a sulfonylurea.

Do all GLP-1 medications come as injections?

No. Ozempic, Wegovy, Mounjaro and Zepbound are injected under the skin once a week, but tablets exist too. Wegovy tablets, Ozempic tablets and Rybelsus contain semaglutide and are taken once a day. Foundayo, a daily tablet containing orforglipron, was first approved in 2026. FitRx does not offer Foundayo.

Can you get a GLP-1 without a prescription?

No. Every GLP-1 medication named on this page requires a prescription. Anything sold over the counter as GLP-1 is not one of these medicines. Compounded semaglutide and compounded tirzepatide also require a prescription. They are not FDA-approved, the FDA does not review them for safety, effectiveness or quality, and they are not generics of the brand-name drugs.

References (18)
  1. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87(4):1409-1439. https://pubmed.ncbi.nlm.nih.gov/17928588/
  2. Drucker DJ. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab. 2018;27(4):740-756. https://pubmed.ncbi.nlm.nih.gov/29617641/
  3. Wegovy (semaglutide) injection and tablets. Prescribing information. Novo Nordisk; revised June 2026. https://www.novo-pi.com/wegovy.pdf
  4. Zepbound (tirzepatide) injection. Prescribing information. Eli Lilly and Company; revised August 2026. https://pi.lilly.com/us/zepbound-uspi.pdf
  5. Ozempic (semaglutide) injection. Prescribing information. Novo Nordisk; revised May 2026. https://www.novo-pi.com/ozempic.pdf
  6. Mounjaro (tirzepatide) injection. Prescribing information. Eli Lilly and Company; revised August 2026. https://pi.lilly.com/us/mounjaro-uspi.pdf
  7. Rybelsus and Ozempic (semaglutide) tablets. Prescribing information. Novo Nordisk; revised January 2026. https://www.novo-pi.com/ozempictablets.pdf
  8. Foundayo (orforglipron) tablets. Prescribing information. Eli Lilly and Company; revised July 2026. https://pi.lilly.com/us/foundayo-uspi.pdf
  9. U.S. Food and Drug Administration. openFDA drug shortages endpoint (FDA Drug Shortages database). https://open.fda.gov/apis/drug/drugshortages/
  10. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
  11. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. https://pubmed.ncbi.nlm.nih.gov/35658024/
  12. Aronne LJ, Horn DB, le Roux CW, et al. Tirzepatide as compared with semaglutide for the treatment of obesity (SURMOUNT-5). N Engl J Med. 2025;393(1):26-36. https://pubmed.ncbi.nlm.nih.gov/40353578/
  13. Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553-1564. https://pubmed.ncbi.nlm.nih.gov/35441470/
  14. Aronne LJ, Sattar N, Horn DB, et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity (SURMOUNT-4). JAMA. 2024;331(1):38-48. https://pubmed.ncbi.nlm.nih.gov/38078870/
  15. Neeland IJ, Linge J, Birkenfeld AL. Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. Diabetes Obes Metab. 2024;26(Suppl 4):16-27. https://pubmed.ncbi.nlm.nih.gov/38937282/
  16. Centers for Disease Control and Prevention. Adult BMI categories. https://www.cdc.gov/bmi/adult-calculator/bmi-categories.html
  17. Hayashi D, Edwards C, Emond JA, et al. What is food noise? A conceptual model of food cue reactivity. Nutrients. 2023;15(22):4809. https://pubmed.ncbi.nlm.nih.gov/38004203/
  18. U.S. Food and Drug Administration. FDA's concerns with unapproved GLP-1 drugs used for weight loss. Content current as of October 1, 2026. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss

Sources were opened and checked on November 18, 2026. Prices, savings programs and labels change; confirm current terms with the manufacturer, your pharmacy or your provider.

Now you know what GLP-1 means. Find out whether one fits you.

Answer a few questions online. A licensed provider reviews your health history and tells you whether GLP-1 medication is appropriate for you.

See if you qualify

FitRx membership costs $39 in month one and $135 a month from then on. Medication is a separate charge. Not everyone qualifies.

A person messaging their FitRx care team in the patient portal on a phone

The FitRx care team

The word is easy to look up. The prescribing decision takes a provider.

Reading about a medication and being prescribed one are different things. FitRx members get a U.S.-licensed provider who checks their health history and current medications before deciding anything, and a care team that answers questions about doses, side effects and insurance paperwork along the way.

  • U.S.-licensed providers review every intake and make every prescribing decision
  • Unlimited secure messaging, plus monthly video or phone visits
  • A care coordinator and a coach alongside your provider
  • An insurance coordination team for brand-name GLP-1 prior authorizations

This page was written and reviewed by the FitRx care team and last updated November 18, 2026. It is general information, not personal medical advice.

GLP-1 medications our providers can prescribe

A provider decides which medication, if any, fits your health history. Compounded semaglutide and compounded tirzepatide are not FDA-approved and are not the same as the brand-name products.